These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic mutations affecting human lipoproteins, their receptors, and their enzymes. Zannis VI; Kardassis D; Zanni EE Adv Hum Genet; 1993; 21():145-319. PubMed ID: 8391199 [No Abstract] [Full Text] [Related]
3. [Genetic factors in the development of atherosclerosis]. Nakajima T; Emi M Nihon Ronen Igakkai Zasshi; 1999 Apr; 36(4):229-33. PubMed ID: 10410563 [No Abstract] [Full Text] [Related]
4. [Abnormal lipoprotein level and the genetic analysis]. Gotoda T; Yamada N Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1825-30. PubMed ID: 1479225 [No Abstract] [Full Text] [Related]
5. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499 [TBL] [Abstract][Full Text] [Related]
6. [Lipid metabolism disorders in patients with chronic renal failure]. Zdrojewski Z Pol Tyg Lek; 1982 May; 37(13):391-3. PubMed ID: 7134045 [No Abstract] [Full Text] [Related]
7. [Role of lipolytic enzymes in the physiopathology of plasma lipoprotein metabolism]. Szeszko A; Lutz W Pol Tyg Lek; 1982 Jul; 37(22):657-61. PubMed ID: 6757901 [No Abstract] [Full Text] [Related]
8. [Methods for studying the metabolism of lipoproteins]. Clavey V; Fruchart JC Ann Endocrinol (Paris); 1983; 44(1):67-71. PubMed ID: 6347028 [TBL] [Abstract][Full Text] [Related]
9. Plasma lipoprotein alterations in thyroid dysfunction. Roles of lipoprotein lipase, hepatic lipase and LCAT. Valdemarsson S Acta Endocrinol Suppl (Copenh); 1983; 255():1-52. PubMed ID: 6575562 [No Abstract] [Full Text] [Related]
10. [Pathophysiology of lipoprotein metabolism]. Windler E; Jäckle S; Rinninger F; Greten H Z Gastroenterol Verh; 1991 Mar; 26():98-9. PubMed ID: 1714219 [No Abstract] [Full Text] [Related]
13. Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis. Dergunov AD; Visvikis-Siest S; Siest G Vascul Pharmacol; 2008; 48(2-3):70-5. PubMed ID: 18221919 [TBL] [Abstract][Full Text] [Related]
14. Disorders of lipid transport: relationship to abnormalities of apoproteins, enzymes and cellular receptors. Schonfeld G Prog Clin Biol Res; 1984; 147():375-402. PubMed ID: 6330755 [No Abstract] [Full Text] [Related]
15. [Recent advanced knowledges related with lipoprotein metabolism]. Shimada K; Mokuno H Nihon Rinsho; 1999 Dec; 57(12):2717-22. PubMed ID: 10638202 [TBL] [Abstract][Full Text] [Related]
16. [Genotyping of hyperlipoproteinemia]. Matsushima T Nihon Rinsho; 1994 Dec; 52(12):3203-9. PubMed ID: 7853711 [TBL] [Abstract][Full Text] [Related]
17. The lipoprotein apoproteins. Their role in normal lipid transport and dyslipoproteinemia. Levy RI; Eisenberg S Ann Biol Clin (Paris); 1974; 32(1):1-8. PubMed ID: 4366057 [No Abstract] [Full Text] [Related]
18. [Biological study of hyperlipemia]. Moulin S LARC Med; 1983 Feb; 3(2):98-103. PubMed ID: 6855393 [No Abstract] [Full Text] [Related]